Cargando…

Hypertonic Saline Administration via Intraosseous Access During Symptomatic Hyponatremia

Hyponatremia is a common lab finding. Symptomatology varies greatly and can depend on the degree of hyponatremia and its chronicity. Causes of hyponatremia are also vast and include heart failure, renal injury, liver disease, and gastrointestinal losses, or it can be induced by medication. Treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Juarez, Angel, Barr, Mitsy, Golden, Thaddeus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10415047/
https://www.ncbi.nlm.nih.gov/pubmed/37575736
http://dx.doi.org/10.7759/cureus.41731
_version_ 1785087436685049856
author Juarez, Angel
Barr, Mitsy
Golden, Thaddeus
author_facet Juarez, Angel
Barr, Mitsy
Golden, Thaddeus
author_sort Juarez, Angel
collection PubMed
description Hyponatremia is a common lab finding. Symptomatology varies greatly and can depend on the degree of hyponatremia and its chronicity. Causes of hyponatremia are also vast and include heart failure, renal injury, liver disease, and gastrointestinal losses, or it can be induced by medication. Treatment depends on the suspected etiology. However, in life-threatening conditions such as seizures or coma, urgent 3% saline is required. Administration of 3% saline is usually through peripheral and central IV access. This case report highlights an alternative route in administering 3% saline, intraosseous vascular access, when other options have been exhausted.
format Online
Article
Text
id pubmed-10415047
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-104150472023-08-11 Hypertonic Saline Administration via Intraosseous Access During Symptomatic Hyponatremia Juarez, Angel Barr, Mitsy Golden, Thaddeus Cureus Emergency Medicine Hyponatremia is a common lab finding. Symptomatology varies greatly and can depend on the degree of hyponatremia and its chronicity. Causes of hyponatremia are also vast and include heart failure, renal injury, liver disease, and gastrointestinal losses, or it can be induced by medication. Treatment depends on the suspected etiology. However, in life-threatening conditions such as seizures or coma, urgent 3% saline is required. Administration of 3% saline is usually through peripheral and central IV access. This case report highlights an alternative route in administering 3% saline, intraosseous vascular access, when other options have been exhausted. Cureus 2023-07-11 /pmc/articles/PMC10415047/ /pubmed/37575736 http://dx.doi.org/10.7759/cureus.41731 Text en Copyright © 2023, Juarez et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Emergency Medicine
Juarez, Angel
Barr, Mitsy
Golden, Thaddeus
Hypertonic Saline Administration via Intraosseous Access During Symptomatic Hyponatremia
title Hypertonic Saline Administration via Intraosseous Access During Symptomatic Hyponatremia
title_full Hypertonic Saline Administration via Intraosseous Access During Symptomatic Hyponatremia
title_fullStr Hypertonic Saline Administration via Intraosseous Access During Symptomatic Hyponatremia
title_full_unstemmed Hypertonic Saline Administration via Intraosseous Access During Symptomatic Hyponatremia
title_short Hypertonic Saline Administration via Intraosseous Access During Symptomatic Hyponatremia
title_sort hypertonic saline administration via intraosseous access during symptomatic hyponatremia
topic Emergency Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10415047/
https://www.ncbi.nlm.nih.gov/pubmed/37575736
http://dx.doi.org/10.7759/cureus.41731
work_keys_str_mv AT juarezangel hypertonicsalineadministrationviaintraosseousaccessduringsymptomatichyponatremia
AT barrmitsy hypertonicsalineadministrationviaintraosseousaccessduringsymptomatichyponatremia
AT goldenthaddeus hypertonicsalineadministrationviaintraosseousaccessduringsymptomatichyponatremia